Template:Implantable Cardioverter Defibrillator ACC/AHA/HRS Guidelines: Difference between revisions
Jump to navigation
Jump to search
Dima Nimri (talk | contribs) (Created page with "{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" |- | colspan="1" style="text-align:center; background:DarkGray" | 200...") |
Dima Nimri (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
{| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | {| class="infobox bordered" style="width: 15em; text-align: left; font-size: 90%; background:AliceBlue" | ||
|- bgcolor="Coral" | |||
! | |||
[[Implantable Cardioverter Defibrillators]] | |||
|- | |||
! | |||
|- | |- | ||
| colspan="1" style="text-align:center; background: | | colspan="1" style="text-align:center; background:LightCoral" | | ||
Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities | |||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Implantable Cardioverter Defibrillators #Implantable Cardioverter-Defibrillators|Implantable Cardioverter-Defibrillators]] | [[Implantable Cardioverter Defibrillators #Implantable Cardioverter-Defibrillators|Implantable Cardioverter-Defibrillators]] | ||
| Line 14: | Line 19: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="Pink" | ||
! | ! | ||
[[Implantable Cardioverter Defibrillators #Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease|Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease]] | [[Implantable Cardioverter Defibrillators #Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease|Implantable Cardioverter-Defibrillators in Pediatric Patients and Patients With Congenital Heart Disease]] | ||
| Line 21: | Line 26: | ||
|- | |- | ||
| colspan="1" style="text-align:center; background: | | colspan="1" style="text-align:center; background:CornFlowerBlue" | | ||
Expert Consensus on the Use of Implantable Cardioverter-Defibrillator Therapy in Patients Who Are Not Included or Not Well Represented in Clinical Trials | |||
|- | |- | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Implantable Cardioverter Defibrillators #ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION|ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION]] | [[Implantable Cardioverter Defibrillators #ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION|ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION]] | ||
| Line 34: | Line 39: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Implantable Cardioverter Defibrillators #ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]|ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]] | [[Implantable Cardioverter Defibrillators #ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]|ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]] | ||
| Line 40: | Line 45: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Implantable Cardioverter Defibrillator #ICD IMPLANTATION WITHIN 90 DAYS OF REVASCULARIZATION|ICD IMPLANTATION WITHIN 90 DAYS OF REVASCULARIZATION]] | [[Implantable Cardioverter Defibrillator #ICD IMPLANTATION WITHIN 90 DAYS OF REVASCULARIZATION|ICD IMPLANTATION WITHIN 90 DAYS OF REVASCULARIZATION]] | ||
| Line 46: | Line 51: | ||
! | ! | ||
|- bgcolor=" | |- bgcolor="LightSkyBlue" | ||
! | ! | ||
[[Implantable Cardioverter Defibrillators #ICD IMPLANTATION <9 MONTHS FROM THE INITIAL DIAGNOSIS OF NONISCHEMIC CARDIOMYOPATHY|ICD IMPLANTATION <9 MONTHS FROM THE INITIAL DIAGNOSIS OF NONISCHEMIC CARDIOMYOPATHY]] | [[Implantable Cardioverter Defibrillators #ICD IMPLANTATION <9 MONTHS FROM THE INITIAL DIAGNOSIS OF NONISCHEMIC CARDIOMYOPATHY|ICD IMPLANTATION <9 MONTHS FROM THE INITIAL DIAGNOSIS OF NONISCHEMIC CARDIOMYOPATHY]] | ||
Revision as of 16:08, 26 October 2016
|
|
|
|
|
ICD IMPLANTATION IN THE CONTEXT OF AN ABNORMAL TROPONIN THAT IS NOT DUE TO A MYOCARDIAL INFARCTION |
|
[[Implantable Cardioverter Defibrillators #ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]|ICD IMPLANTATION WITHIN 40 DAYS OF A MYOCARDIAL INFARCTION]] |
|
ICD IMPLANTATION <9 MONTHS FROM THE INITIAL DIAGNOSIS OF NONISCHEMIC CARDIOMYOPATHY |